Health and Advocacy Leaders Mobilize to Bring Attention to Atrial Fibrillation, a Costly and Misunderstood Cardiovascular Disease
Posted on: Monday, 18 May 2009, 08:05 CDT
Survey Shows Patient and Healthcare Professionals are 'Out of Sync' About
Potential Serious Health Consequences
Approximately 2.5 million Americans currently have AFib, but because the risk increases with age, this number is expected to rise dramatically as the U.S. population gets older(1). Characterized by a very irregular and frequently fast heart rate, AFib is associated with a five-fold increase in risk for stroke(2); worsens underlying cardiovascular disease(3) and doubles the risk of all-cause mortality(4). It also costs the nation
"Reducing the impact of chronic diseases is an essential component to health reform discussions," said Senator
The AF Stat Working Group brings together leaders representing 24 advocacy, medical professional, aging, caregiver, employer, payer and cardiovascular organizations. The group's first goal is to draft an AF Call to Action outlining the barriers and priority steps needed to improve AFib management. The group will then work together to implement those actions.
"AFib is emotionally and physically draining and the risks are potentially debilitating," noted NBA Hall of Famer
"Out of Sync: The State of AFib" Survey
Today's release of a survey measuring physician, nurse and patient AFib experiences and attitudes, "Out of Sync: The State of AFib", shows that Mr. West is not alone in his search for information, reinforcing the need for AF Stat.
The survey measured the experiences and attitudes of physicians, nurses and patients with AFib. The results indicate a clear disconnect between medical professionals and patients about their understanding of AFib and its risks, demonstrating a need for better educational resources:
- Less than half of AFib patients fully appreciate or recognize the health consequences of the condition, particularly their increased risk of stroke and heart failure:
- While almost all physicians (97 percent) think their AFib patients are at severe/moderate risk of stroke, less than half (45 percent) of AFib patients think they are at risk.
- More than 90 percent of physicians think their AFib patients are at severe/moderate risk of death from heart-related causes. In contrast, fewer than 40 percent of patients think they are at risk.
- More than half of doctors (53 percent) believe there is a lack of available support and materials for patients with AFib; 42 percent of doctors reported having to use their own drawings, as opposed to using charts, posters or anatomical models, to guide patient discussions about AFib, while nurses report using their hands or charts/posters(6).
"The complex nature of AFib requires individualized patient care and is a major barrier to optimal management and underscores the need for comprehensive education on AFib for a wide range of audiences," said
About the "Out of Sync" Survey
"Out of Sync: The State of AFib in America" survey was conducted by Yankelovich, part of the Futures Company, to compare the perspectives of patients who have been diagnosed with AFib, and the physicians and nurses who treat the patients with the disease. Survey results were obtained through online interviews among 200 doctors and 200 nurses who treat AFib patients, and 500 AFib patients, representative of a national sample. Interviews took place between
About AF Stat(TM): A Call to Action for Atrial Fibrillation
AF Stat is a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by atrial fibrillation. AF Stat is raising awareness of AFib as a complex, costly, progressive and often debilitating disease. It also is calling for and helping promote a change in attitudes and behaviors to enhance AFib understanding, diagnosis and management. AF Stat is an initiative sponsored by sanofi-aventis U.S. LLC.
AF Stat(TM): A Call to Action for Atrial Fibrillation is an initiative sponsored by sanofi-aventis U.S. LLC
(1) Go, A. Prevalence of Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA,
(2)
(3) Fuster V, Ryden LE, Cannom DS, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e257-e354.
(4) Benjamin EJ,
(5) Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds MR, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in
(6) Out of Sync: The State of AFib in America Survey. Conducted by Yankelovich, Part of the Futures Company March-April, 2009. Sponsored by sanofi-aventis.
SOURCE AF Stat Working Group
Source: PR Newswire
Related Articles
- FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
- Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients With Atrial Fibrillation
- Atrial Fibrillation Found to Be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke
- Further Analysis From ATHENA Study Showed That Multaq(R) (Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
- Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
- Multaq(R) (Dronedarone) Granted FDA Priority Review for Patients With Atrial Fibrillation
- Landmark ATHENA Study Findings With Multaq(R) (Dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
- Minimally Invasive Bi-Atrial Lesion Pattern Produces Positive Results in Patients With Atrial Fibrillation
- Use of Propafenone Hydrocloride Supported in New ACC/AHA/ESC Practice Guidelines for Managing Patients With Atrial Fibrillation; New Treatment Algorithm Recommends Propafenone As First-Line Antiarrhythmic Therapy Option
User Comments (0)

RSS Feeds